Y, A., MH, H., L, M., XX, L., Y, T., C, B., . . . GL, D. (2026). CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment. Clinical and experimental medicine, 26(1), . https://doi.org/10.1007/s10238-026-02101-x
Chicago Style (17th ed.) CitationY, Adeerjiang, et al. "CD44 Is Associated with Papillary Thyroid Carcinoma Metastasis via Potential Modulation of the Immunosuppressive Tumor Microenvironment." Clinical and Experimental Medicine 26, no. 1 (2026). https://doi.org/10.1007/s10238-026-02101-x.
MLA (9th ed.) CitationY, Adeerjiang, et al. "CD44 Is Associated with Papillary Thyroid Carcinoma Metastasis via Potential Modulation of the Immunosuppressive Tumor Microenvironment." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10238-026-02101-x.